Related references
Note: Only part of the references are listed.Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency
Go Sugahara et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2021)
A deep intronic variant is a common cause of OTC deficiency in individuals with previously negative genetic testing
Runjun D. Kumar et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2021)
Investigation of Clinical Safety of Human iPS Cell-Derived Liver Organoid Transplantation to Infantile Patients in Porcine Model
Tomonori Tsuchida et al.
CELL TRANSPLANTATION (2020)
Urea cycle disorders-update
Shirou Matsumoto et al.
JOURNAL OF HUMAN GENETICS (2019)
Natural Flavonol, Myricetin, Enhances the Function and Survival of Cryopreserved Hepatocytes In Vitro and In Vivo
Changhao Cui et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Modeling lethal X-linked genetic disorders in pigs with ensured fertility
Hitomi Matsunari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
AAV gene therapy corrects OTC deficiency and prevents liver fibrosis in aged OTC-knock out heterozygous mice
Lili Wang et al.
MOLECULAR GENETICS AND METABOLISM (2017)
FETAL GENE THERAPY FOR ORNITHINE TRANSCARBAMYLASE DEFICIENCY BY INTRAHEPATIC PLASMID DNA-MICRO-BUBBLE INJECTION COMBINED WITH HEPATIC ULTRASOUND INSONATION
Yoshie Oishi et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2016)
Hepatocyte transplantation using a living donor reduced graft in a baby with ornithine transcarbamylase deficiency: A novel source of hepatocytes
Shin Enosawa et al.
LIVER TRANSPLANTATION (2014)
Long-term outcome and intervention of urea cycle disorders in Japan
Jun Kido et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2012)
Production of transgenic and non-transgenic clones in miniature pigs by somatic cell nuclear transfer
Mayuko Kurome et al.
JOURNAL OF REPRODUCTION AND DEVELOPMENT (2008)
Share Paper
